lobbying_activities: 3237377

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3237377	4b3f358f-b58d-4b43-8fbe-522fe90c2fc8	Q3	THE PETRIZZO GROUP, INC.	305932	OMEROS CORPORATION	2024	third_quarter	MED	Development and execution of initiatives involving multiple Omeros pipeline targets before the U.S. Government, including funding collaborations associated with COVID, Cancer, and addition within the Department of HHS, NIH, BARDA, and the White House. FDA Rare Disease Center of Excellence	Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE	75000		0	0	2024-10-14T19:25:01-04:00